Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review

Open access
Hemilä, Harri · 2011 · The Open Respiratory Medicine Journal

Abstract

BACKGROUND: A number of controlled trials have examined the effect of zinc lozenges on the common cold but the findings have diverged. The purpose of this study was to examine whether the total daily dose of zinc might explain part of the variation in the results. METHODS: The Medline, Scopus and Cochrane Central Register of Controlled Trials data bases were searched for placebocontrolled trials examining the effect of zinc lozenges on common cold duration. Two methods were used for analysis: the P-values of the trials were combined by using the Fisher method and the results of the trials were pooled by using the inverse-variance method. Both approaches were used for all the identified trials and separately for the low zinc dose and the high zinc dose trials. RESULTS: Thirteen placebo-controlled comparisons have examined the therapeutic effect of zinc lozenges on common cold episodes of natural origin. Five of the trials used a total daily zinc dose of less than 75 mg and uniformly found no effect. Three trials used zinc acetate in daily doses of over 75 mg, the pooled result indicating a 42% reduction in the duration of colds (95% CI: 35% to 48%). Five trials used zinc salts other than acetate in daily doses of over 75 mg, the pooled result indicating a 20% reduction in the duration of colds (95% CI: 12% to 28%). CONCLUSIONS: This study shows strong evidence that the zinc lozenge effect on common cold duration is heterogeneous so that benefit is observed with high doses of zinc but not with low doses. The effects of zinc lozenges should be further studied to determine the optimal lozenge compositions and treatment strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1874306401105010051

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) The effect of zinc lozenges on the duration of the common cold. The trials are in the same order as in Table 1, from the highest daily dose of zinc to the lowest dose. They are divided into the same high dose and low dose subgroups as in Table 2. In the forest plot on the right side, the vertical line indicates the placebo level. The horizontal line indicates the 95% CI for the effect and the square in the middle of the horizontal line indicates the point estimate of the effect in the particular trial. Three diamond shapes indicate the pooled effects and their 95% CI:s for the two subgroups and for all trials. The duration of colds has been transformed to the relative scale so that the duration in the placebo group is given the value of 100%. Thereby the difference between zinc and placebo groups directly indicates the effect of zinc lozenges in percentages. See Supplementary Material 2 and Supplementary Material 3 for the extraction of the data and for the calculation of the relative mean and SD values for the common cold duration.
Fig. (1) The effect of zinc lozenges on the duration of the common cold. The trials are in the same order as in Table 1, from the highest daily dose of zinc to the lowest dose. They are divided into the same high dose and low dose subgroups as in Table 2. In the forest plot on the right side, the vertical line indicates the placebo level. The horizontal line indicates the 95% CI for the effect and the square in the middle of the horizontal line indicates the point estimate of the effect in the particular trial. Three diamond shapes indicate the pooled effects and their 95% CI:s for the two subgroups and for all trials. The duration of colds has been transformed to the relative scale so that the duration in the placebo group is given the value of 100%. Thereby the difference between zinc and placebo groups directly indicates the effect of zinc lozenges in percentages. See Supplementary Material 2 and Supplementary Material 3 for the extraction of the data and for the calculation of the relative mean and SD values for the common cold duration.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 60 references

Research works printed but not linked: 1

  1. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration http://ims.cochrane.org/revman 2011.

Cited by

See all 89

Metadata

Authors
Hemilä, H.
Affiliations
University of Helsinki (FI)
Corresponding author
Hemilä, Harri
Venue
The Open Respiratory Medicine Journal
Published
2011-06-23
Volume
05
Issue
1
Pages
51-58
ISSN
1874-3064 (ISSN-L)
OpenAlex
W1568841878
Cited by
89
References
60
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 15 · 2020: 18 · 2019: 1 · 2018: 1 · 2017: 9 · 2016: 2 · 2015: 7 · 2014: 4 · 2013: 5 · 2012: 3
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • The Open Respiratory Medicine Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Herbal Medicine Research Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
zinc lozenges, common cold, cold duration, zinc acetate, zinc salts, dose-response relationship

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review. https://app.cochat.ai/papers/10.2174/1874306401105010051
The paper
Hemilä, H. (2011). Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review. The Open Respiratory Medicine Journal. https://doi.org/10.2174/1874306401105010051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.